{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:53Z","timestamp":1740120113884,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:00:00Z","timestamp":1663804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s12185-022-03458-x","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T04:03:31Z","timestamp":1663819411000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful pseudo-autologous stem cell transplantation for donor-derived Burkitt lymphoma occurring 9 years after allogeneic transplantation"],"prefix":"10.1007","volume":"117","author":[{"given":"Shiho","family":"Taniguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sae","family":"Utsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Taya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6425-1720","authenticated-orcid":false,"given":"Yasuo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ichiro","family":"Semba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohta","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikane","family":"Kikushige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Kunisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goichi","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,22]]},"reference":[{"issue":"7693","key":"3458_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0140-6736(71)90998-6","volume":"1","author":"PJ Fialkow","year":"1971","unstructured":"Fialkow PJ, Bryant JI, Thomas ED, Neiman PE. Leukaemic transformation of engrafted human marrow cells in vivo. Lancet. 1971;1(7693):251\u20135.","journal-title":"Lancet"},{"issue":"8","key":"3458_CR2","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/leu.2016.23","volume":"30","author":"M Kato","year":"2016","unstructured":"Kato M, Yamashita T, Suzuki R, Matsumoto K, Nishimori H, Takahashi S, et al. Donor cell-derived hematological malignancy: a survey by the Japan society for hematopoietic cell transplantation. Leukemia. 2016;30(8):1742\u20135.","journal-title":"Leukemia"},{"issue":"7","key":"3458_CR3","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","volume":"21","author":"KS Baker","year":"2003","unstructured":"Baker KS, Defor TE, Burns LJ, Ramsay NKC, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21(7):1352\u20138.","journal-title":"J Clin Oncol"},{"issue":"6","key":"3458_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bbmt.2010.10.010","volume":"17","author":"DH Wiseman","year":"2011","unstructured":"Wiseman DH. Donor cell leukemia: a review. Biol Blood Marrow Transpl. 2011;17(6):771\u201389.","journal-title":"Biol Blood Marrow Transpl"},{"issue":"27","key":"3458_CR5","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","volume":"28","author":"C Gisselbrecht","year":"2010","unstructured":"Gisselbrecht C, Glass B, Mounier N, Gill DS, Linch DC, Trneny M, et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28(27):4184\u201390.","journal-title":"J Clin Oncol"},{"issue":"31","key":"3458_CR6","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1200\/JCO.2013.53.9593","volume":"32","author":"M Crump","year":"2014","unstructured":"Crump M, Kuruvilla J, Couban S, MacDonald DA, Kukreti V, Kouroukis CT, et al. Randomized comparison of gemcitabine, dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12. J Clin Oncol. 2014;32(31):3490\u20136.","journal-title":"J Clin Oncol"},{"issue":"18","key":"3458_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1056\/NEJMoa1301077","volume":"369","author":"PJ Stiff","year":"2013","unstructured":"Stiff PJ, Unger JM, Cook JR, Constine LS, Couban S, Stewart DA, et al. Autologous transplantation as consolidation for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 2013;369(18):1681\u201390.","journal-title":"N Engl J Med"},{"issue":"33","key":"3458_CR8","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1200\/JCO.2016.67.2980","volume":"34","author":"S Cortelazzo","year":"2016","unstructured":"Cortelazzo S, Tarella C, Gianni AM, Ladetto M, Barbui AM, Rossi A, et al. Randomized trial comparing R-CHOP versus high-dose sequential chemotherapy in high-risk patients with diffuse large B-cell lymphomas. J Clin Oncol. 2016;34(33):4015\u201322.","journal-title":"J Clin Oncol"},{"issue":"8","key":"3458_CR9","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.bmt.1703550","volume":"29","author":"I Pusic","year":"2002","unstructured":"Pusic I, Pavletic SZ, Kessinger A, Tarantolo SR, Bishop MR. Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease. Bone Marrow Transpl. 2002;29(8):709\u201310.","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"3458_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/MPH.0b013e318241fcf1","volume":"34","author":"TH Jaing","year":"2012","unstructured":"Jaing TH, Tseng CK, Mun-Ching Wong A, Lo WC, Wu CT, et al. Rescue by hematopoietic progenitor cells derived from engrafted cord blood unit in a child with brain tumor after transplantation for T-cell acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2012;34(7):573\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"3458_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12185-017-2296-z","volume":"107","author":"M Tamaki","year":"2018","unstructured":"Tamaki M, Wada H, Gomyo A, Hayakawa J, Akahoshi Y, Harada N, et al. Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation. Int J Hematol. 2018;107:117\u201321.","journal-title":"Int J Hematol"},{"issue":"8","key":"3458_CR12","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/bmt.2013.12","volume":"48","author":"E Palfreyman","year":"2013","unstructured":"Palfreyman E, Song K, Nantel S. Pseudo-autologous hematopoietic SCT as treatment for a patient with multiple myeloma who relapsed following an allogeneic SCT. Bone Marrow Transpl. 2013;48(8):1138.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"3458_CR13","first-page":"428","volume":"56","author":"M Hatsuse","year":"2015","unstructured":"Hatsuse M, Taniguchi-Yoshihara K, Yagyu S, Fuchida S, Okano A, Murakami S, et al. Successful treatment with pseudo\u2014autologous blood stem cell transplantation for an adolescent-onset multiple myeloma who relapsed after allogeneic bone marrow transplantation. Rinsho Ketsueki. 2015;56(4):428\u201331.","journal-title":"Rinsho Ketsueki"},{"issue":"4","key":"3458_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s12185-017-2389-8","volume":"107","author":"T Miyamoto","year":"2018","unstructured":"Miyamoto T, Nagafuji K, Fujisaki T, Uchida N, Matsue K, Henzan H, et al. Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission. Int J Hematol. 2018;107(4):468\u201377.","journal-title":"Int J Hematol"},{"issue":"3","key":"3458_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National institute of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transpl. 2015;21(3):389\u2013401.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3458_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s12185-009-0370-x","volume":"90","author":"T Teshima","year":"2009","unstructured":"Teshima T, Nagafuji K, Henzan H, Miyamura K, Takase K, Hidaka M, et al. Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease. Int J Hematol. 2009;90:253\u201360.","journal-title":"Int J Hematol"},{"key":"3458_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","volume":"22","author":"KM Williams","year":"2016","unstructured":"Williams KM, Chen GS, Pusic I, Jagasia M, Burns L, Ho VT, et al. Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transpl. 2016;22:710\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3458_CR18","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44:1321\u20135.","journal-title":"Nat Genet"},{"key":"3458_CR19","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1182\/blood.2019001880","volume":"134","author":"RI Panea","year":"2019","unstructured":"Panea RI, Love CL, Shingleton JR, Reddy A, Bailey JA, Moormann AM, et al. The whole-genome landscape of Burkitt lymphoma subtypes. Blood. 2019;134:1598\u2013607.","journal-title":"Blood"},{"key":"3458_CR20","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","volume":"369","author":"K Dunleavy","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, et al. Low-intensity therapy in adults with Burkitt\u2019s lymphoma. N Engl J Med. 2013;369:1915\u201325.","journal-title":"N Engl J Med"},{"key":"3458_CR21","first-page":"635","volume":"35","author":"M Okamoto","year":"1994","unstructured":"Okamoto M, Maruyama F, Tsuzuki M, Nomura T, Miyazaki H, Wakita M, et al. Salvage chemotherapy for relapsed\/refractory aggressive non-Hodgkin\u2019s lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin. Rinsho Ketsueki. 1994;35:635\u201341.","journal-title":"Rinsho Ketsueki"},{"key":"3458_CR22","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00277-016-2740-9","volume":"95","author":"M Sugimoto","year":"2016","unstructured":"Sugimoto M, Ito S, Mashima K, Umino K, Minakata D, Nakano H, et al. Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan. Ann Hematol. 2016;95:1513\u20139.","journal-title":"Ann Hematol"},{"issue":"7","key":"3458_CR23","first-page":"969","volume":"90","author":"B Hertenstein","year":"2005","unstructured":"Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S, et al. Development of leukemia in donor cells after allogeneic stem cell transplantation: a survey of the European group for blood and marrow transplantation (EBMT). Haematologica. 2005;90(7):969\u201375.","journal-title":"Haematologica"},{"issue":"2","key":"3458_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bjh.12847","volume":"166","author":"AC Dietz","year":"2014","unstructured":"Dietz AC, DeFor TE, Brunstein CG, Wagner JE Jr. Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response. Br J Haematol. 2014;166(2):209\u201312.","journal-title":"Br J Haematol"},{"key":"3458_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138.","journal-title":"Nature"},{"key":"3458_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","volume":"9","author":"ZR Chalmers","year":"2017","unstructured":"Chalmers ZR, Connelly CF, Fabrizio D, Gay L, Ali SM, Ennis R, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9:34.","journal-title":"Genome Med"},{"issue":"4","key":"3458_CR27","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/ard.2005.037879","volume":"65","author":"H Tsukamoto","year":"2006","unstructured":"Tsukamoto H, Nagafuji K, Horiuchi T, Miyamoto T, Aoki K, Takase K, et al. A phase I\u2013II trial of autologous peripheral blood stem cell transplantation in the treatment of refractory autoimmune disease. Ann Rheum Dis. 2006;65(4):508\u201314.","journal-title":"Ann Rheum Dis"},{"key":"3458_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13075-019-1823-0","volume":"21","author":"M Ayano","year":"2019","unstructured":"Ayano M, Tsukamoto H, Mitoma H, Kimoto Y, Akahoshi M, Arinobu Y, et al. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I\/II clinical trial conducted in Japan. Arthr Res Ther. 2019;21:30.","journal-title":"Arthr Res Ther"},{"key":"3458_CR29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641\u201350.","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03458-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03458-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:59:00Z","timestamp":1675184340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03458-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,22]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3458"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03458-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2022,9,22]]},"assertion":[{"value":"28 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest about this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}